Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × durvalumab × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Completed 92 Active not recruiting 85 Recruiting 83 Unknown 42 Withdrawn 32 Terminated 29 Not yet recruiting 16 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 8 Biopsy 8 pembrolizumab 4 Paclitaxel 4 Nivolumab 4 Cisplatin 4 Capecitabine 4 spartalizumab 3 Vincristine 3 Radiosurgery 3 Irinotecan 3 Fluorouracil 3 Etoposide 3 Docetaxel 3 Dexamethasone 3 Cyclophosphamide 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 lenvatinib 2 daratumumab 2 balstilimab 2 atezolizumab 2 Taxes 2 Radiation 2 Prednisone 2 Pemetrexed 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05903092 2026-04-07

MOZART

Hoosier Cancer Research Network

Phase 2 Suspended

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡